Status:
UNKNOWN
Preoperative Nerve Block for Rhinoplasty/Septoplasty
Lead Sponsor:
University of Southern California
Conditions:
Nasal Fracture
Deviated Nasal Septum
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Addiction is an inherent risk when prescribing opiates for pain relief, and methods to reduce its use or amount prescribed can help mitigate this risk for addiction. Patients undergoing rhinoplasty ar...
Detailed Description
With the current opioid epidemic, more than 40,000 deaths can be attributed to prescription and illicit opioid use per year. There is inherent risk for patients to develop addiction when prescribing o...
Eligibility Criteria
Inclusion
- Any patient requiring rhinoplasty/septoplasty and able to provide consent.
- Must be willing to participate.
- Must be able to complete consent in English or Spanish.
Exclusion
- History of opioid substance abuse disorder.
- \<18 years old
- Currently pregnant
Key Trial Info
Start Date :
June 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03780478
Start Date
June 17 2019
End Date
March 1 2022
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keck Medical Center
Los Angeles, California, United States, 90033